• Curaleaf secured all required competition clearances in Germany and Canada for its proposed acquisition of Aurora Cannabis.
• The offer covers all outstanding Aurora common shares; the enhanced bid dated October 6, 2026, expires December 4 unless withdrawn or amended.
• Completion remains subject to the offer's remaining conditions being satisfied or waived.
• Rival bidder Organigram's proposed acquisition still requires shareholder, court and regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611100745PR_NEWS_USPR_____NE93670) on November 10, 2026, and is solely responsible for the information contained therein.